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ABSTRACT
PROTEST-RELATED TEAR GAS EXPOSURE AND MENSTRUAL FUNCTION
Emily K. Reece
April 14, 2022
During the racial justice protests of 2020 and 2021, crowd control chemical
irritants (referred to as “tear gas”) were deployed against protesters, after which there
were anecdotal reports of altered menstrual cycles among exposed individuals. There is
only one peer reviewed published study on tear gas exposure and menstrual health. This
study examined whether tear gas exposure was associated with menstrual cycle outcomes
among women attending the 2020-2021 protests.
Data from 103 women who attended racial justice protests in 2020 and 2021 were
collected through an online questionnaire. Data included protest attendance, acute
symptoms of tear gas exposure, whether medical care was sought for acute effects of tear
gas exposure, and menstrual cycle outcomes. The associations between proxy
measurements of tear gas exposure and menstrual cycle symptoms were determined
through linear regression, adjusted for covariates. The proxies for tear gas exposure were
number of protests attended; total number of acute symptoms of exposure; acute
symptoms experienced in specific organ systems (eye, lung, skin, heart); and seeking
medical care after exposure (yes/no). The outcome variables were total number of
menstrual cycle outcomes, and two factors identified through exploratory factory
analysis: factor 1 – intense outcomes (heavy bleed, long bleed, short bleed, long cycle,
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irregular cycles, and period pain) and factor 2 – milder outcomes (light bleed, short bleed,
and short cycle). All models were adjusted for age, race, ethnicity, education, income,
and trying to conceive.
Higher protest attendance (> 9) had significant positive associations with total
number of menstrual cycle symptoms (β: 2.12, 95% CI: 1.12, 3.11) and factor 1 (β: 1.22,
95% CI: 0.79, 1.65). Seeking medical care for tear gas exposure had a significant inverse
association with factor 1 (β: -0.95, 95% CI: -1.56, -0.34), but was not associated with
total number of menstrual cycle symptoms or factor 2. The total number of acute
symptoms and acute symptoms in specific organ systems were not significantly
associated with menstrual cycle outcomes. Results may be confounded by stress
experienced during protests. Additional research is needed to determine whether there are
long-term menstrual cycle and reproductive health outcomes after exposure to tear gas.
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INTRODUCTION

Overview
The years of 2020 and 2021 saw a marked increase in racial justice protests and
demonstrations as part of the Black Lives Matter movement. The protestors involved in
racial justice protests have frequently been met with the use of crowd control chemical
irritants, such as tear gas and pepper spray, by law enforcement agencies (1). The
widespread and ongoing nature of these protests creates the potential for a large number
of individuals to be exposed to these irritants (2). Tear gas and pepper spray are intended
as transient incapacitants, which work by inducing uncontrollable tearing (lacrimation),
coughing and sneezing. While tear gas and pepper spray are considered safer than more
forceful measures of crowd control and their effects are considered temporary when
tested in healthy volunteers, there are still questions about the overall safety and longerterm effects when used on the general population (3, 4).
The main lacrimator agent in tear gas can be one of several compounds. These
include 2-chlorobenzylidene malononitrile (CS), 1-chloroacetophenone (CN), and dibenz
[Ƅ,ƒ]-1,4-oxazepine (CR) (3). Tear gas agents can be deployed as aerosolized solids
(projectile pellets and pyrotechnic canisters) or as liquid sprays (3). The active ingredient
in pepper spray is oleoresin capsicum (OC), which is an oil isolated from hot peppers, or
a synthetic analogue (pelargonic acid vanillylamide or capsaicin II) (4). Deployment
methods for pepper spray include the use of liquid sprays and aerosolized solids
1

(projectile pellets) (3). Of these lacrimating agents, CS and OC are the most common as
they are considered the safest options (4).
While the immediate effects of tear gas and pepper spray on eyes, lungs, and skin
are well documented, effects on other organ systems are not. One potential health effect
that has not been well studied is altered menstrual function. Menstrual function includes
menstrual cycle length (the first day of menstrual bleeding until the day before the start of
the next menstrual bleeding), bleed length, and bleed intensity. These characteristics can
be indicative of reproductive health and have been associated with fertility and
reproductive cancers (5, 6). The following review of literature outlines the biology behind
the menstrual cycle and ovulation, known effects of tear gas and pepper spray, and
studies of tear gas in relation to the reproductive system. The literature suggest that tear
gas may affect the reproductive system by disrupting the endocrine system that
orchestrates it.

Menstrual Function and Ovulation
To understand how tear gas and pepper spray might affect menstrual health, the
characteristics of normal functioning of the menstrual cycle and ovulation must first be
established. The following section outlines the phases of the menstrual and ovarian cycles
and the associated hormone actions and fluctuations.
The menstrual cycle and ovulation are coordinated through the interplay of
several hormones. These include gonadotropin releasing hormone (GnRH), follicle
stimulating hormone (FSH), luteinizing hormone (LH), estradiol, progesterone, and the
2

proteins inhibin A and inhibin B (7). GnRH is produced in pulses by the hypothalamus
and stimulates the pituitary to release FSH and LH (7). FSH and LH both work on the
ovaries. FSH stimulates ovarian follicles to release estradiol and LH stimulates the
follicles to release estrogen. Estradiol and estrogen both act on the uterus. Estradiol also
has a negative feedback function on the production of GnRH by the hypothalamus and a
positive feedback function on the production of FSH and LH by the pituitary (7). Inhibin
A and Inhibin B are protein dimers secreted by ovarian follicles and the corpus luteum
(7). Inhibin A release is stimulated by both FSH and LH (7). FSH also causes inhibin B
levels to rise by stimulating proliferation of the cells in the follicle and corpus luteum that
secrete it (7). Inhibins A and B suppress FSH secretion by the pituitary (7). The
hypothalamus, pituitary, and reproductive organs are known as the hypothalamuspituitary-gonadal axis (HPG axis) [Figure 1].
Figure 1: The Hypothalamus-Pituitary-Gonadal Axis
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The menstrual cycle is divided into two phases: the follicular (or proliferative)
phase and the luteal (or secretory) phase [Figure 2]. The follicular phase begins with the
onset of menstrual bleeding and ends the day before ovulation (7). The first day of the
follicular phase is also the first day of the menstrual cycle. The average day of ovulation
is day 14 of the cycle. The menstrual bleeding that defines the beginning of the follicular
phase generally lasts seven to nine days (8). In these initial days, GnRH, LH, estrogen,
and estradiol release are relatively low, while FSH is at its highest (9). The elevated FSH
stimulates the recruitment of several ovarian follicles, which began maturing in the
preceding late luteal phase (9). As a dominant follicle emerges around the 5th to 7th day
and begins to release inhibin B, FSH levels drop, further favoring the dominant follicle
(9). During this same period, the uterine lining proliferates to build the endometrium back
up in preparation for a fertilized ovum (7).
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Figure 2: Changes in Hormones, Ovaries, and Endometrium Over the Menstrual
Cycle

Reed et al. 2000 (9)

In the middle of the follicular phase, GnRH release increases, but LH production
is still depressed by the estradiol made by the dominant follicle (7). As the follicular
phase progresses, the level of estradiol released by the dominant follicle rapidly
increases, which engages the positive feedback loop to the pituitary, leading to a surge in
FSH and LH (7). The LH surge triggers ovulation approximately 36 hours later (7).
The luteal phase follows ovulation and lasts approximately 14 days (9). The postovulatory remains of the dominant follicle in the ovary form the corpus luteum and begin
5

to secrete progesterone and estradiol and continue to secrete inhibin A (9). The increase
in progesterone and estradiol causes the release of GnRH from the hypothalamus (7). In
the middle of the luteal phase and in the absence of fertilization and implantation, the
corpus luteum begins to functionally decline (7). As it secretes less progesterone and
estradiol, suppression of FSH production in the pituitary eases (7). The decline in
progesterone, which was supporting the blood supply to the endometrium that had
formed during the follicular phase, causes the endometrium to begin to degrade (9). The
luteal phase ends the day before the onset of menstrual bleeding (7).
The ovaries contain a population of resting primary follicles (10). These are
composed of an oocyte enclosed in a single layer of granulosa cells which provide
metabolic support (11). Follicles are recruited in multiple waves during the menstrual
cycle (10). Each wave can include 4 to 14 follicles (10). During recruitment, FSH and LH
stimulate the primary follicles to become secondary follicles, which become more
metabolically active; and the granulosa cells form multiple layers and develop an external
layer of theca cells (10, 11). FSH then further stimulates the secondary follicles to form
fluid-filled cavities surrounded by granulosa cells (10). At this stage, the follicles are
referred to as atrial follicles (10). The dominant atrial follicle will go on to develop into a
large Graafian follicle, with an expanded fluid pocket and a larger number of granulosa
cells (10). This is the mature follicle that will be ovulated (10).
While follicles can be recruited during several points in the menstrual cycle,
follicle maturation and selection of the dominant follicle occur during the follicular phase
(10). The elevated levels of FSH in the follicular phase promote follicle maturation, and
as follicles mature, less viable follicles die off (10). As one follicle becomes dominant, it
6

begins secreting estrogen, which suppresses the FSH that has been supporting the less
developed recruited follicles (12). The estrogen suppresses FSH production until a
threshold is met, and then it stimulated the release of FSH followed closely by LH (the
LH surge) (10). The FSH surge prepares the dominant follicle for ovulation, and the LH
surge causes the rupture of the follicle that releases the oocyte in ovulation and its
immediately surrounding granulosa cells (11).
In the luteal phase, the granulosa cells that remain in the ovary after ovulation
take on a yellow pigmentation and become more vascularized to form the corpus luteum
(10, 11). The corpus luteum produces progesterone and estradiol to maintain the
endometrium for implantation. If implantation does not occur, the corpus luteum
regresses and forms a white scar called the corpus albicans (11). The cycle of follicle
recruitment, maturation, and selection then begins again as the next follicular phase
begins.
The thyroid also plays an important role in menstrual function and ovulation,
though the mechanisms are not as well defined as for the HPG axis. The coordinated
functioning of the hypothalamus, pituitary, and thyroid is known as the hypothalamuspituitary-thyroid axis (HPT axis) [Figure 3]. In the HPT axis, the hypothalamus secretes
thyroid releasing hormone (TRH) which stimulates the pituitary to release thyroid
stimulating hormone (TSH). In response to TSH, the thyroid secretes thyroid hormones
(THs) T3 and T4 (13). T3 has a negative feedback effect on the secretion of TRH and
TSH (13). T3 stimulates granulosa cells and is believed to also play a role in ovulation,
endometrium proliferation, and placental development (13, 14). The importance of the
thyroid to reproductive functions is demonstrated by the association that abnormally low
7

thyroid activity (hypothyroidism) and abnormally high thyroid activity (hyperthyroidism)
have with fertility issues as well as a number of menstrual disorders (14, 15).
Figure 3: The Hypothalamus-Pituitary-Thyroid Axis and the Female Reproductive
System

Menstrual Disorders
Menstrual disorders occur when the interplay of hormones detailed above is
disrupted. These disorders include the absence of bleeding (amenorrhea), short or light
bleeding (hypomenorrhea), heavy or long bleeding (menorrhagia), period pain
(dysmenorrhea), cycles of less than 21 days (polymenorrhea), cycles that are irregular or
more than 35 days (oligomenorrhea), and bleeding between periods (metrorrhagia) (16).
Amenorrhea, hypomenorrhea, menorrhagia, polymenorrhea, oligomenorrhea, and
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metrorrhagia are also referred to as abnormal uterine bleeding (AUB) (17). AUB is
estimated to affect 14% to 25% of women during their reproductive years (17).
Understanding the risk factors associated with developing menstrual disorders such as
AUB is important as they can impact both the quality of life and professional
performance of affected women (18).
Excessive menstrual bleeding (heavy, long, or frequent bleeding) has many
known underlying causes and risk factors. Known causes include coagulation disorders;
uterine fibroids; endometrial polyps; adenomyosis, in which the uterine lining grows into
the uterine wall; cancer; polycystic ovarian syndrome (PCOS), hypothyroidism, and
anovulatory cycles (15, 17). Risk factors for excessive bleeding include hypoxia;
extremes of the reproductive age range; and some medications, such as blood thinners,
corticosteroids, antipsychotics, and tricyclene antidepressants (17, 19).
Long or irregular cycles affect approximately 14% of women of childbearing age
(20). This irregularity can be caused by PCOS, hyperthyroidism, hypothyroidism,
androgen secreting tumors, diabetes, adrenal hyperplasia, Cushing syndrome, and pelvic
inflammatory disease (15, 20). Risk factors include recent menarche or nearing
menopause, stress, and antipsychotic medications (15, 20).
Metrorrhagia, which is also known as spotting, breakthrough bleeding, or
intermenstrual bleeding, is a common side effect of many forms of hormonal birth
control. Smoking and sexually transmitted infections increase the risk of spotting.
Breakthrough bleeding can also be caused by uterine fibroids (21).
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Amenorrhea, or lack of menstrual bleeding for at least three cycles, is experienced
by approximately 1% of women in the United States (22). Amenorrhea is often associated
with pregnancy, but there are other known causes and risk factors (15). Nutritional
deficiencies, such as those caused by anorexia and bulimia; extreme exercise;
antipsychotic medications; and psychological stress are all risk factors for amenorrhea
(15). Additional causes include PCOS, hypothyroidism, hyperthyroidism, ovarian failure,
and hyperprolactemia (23, 24). Some types of birth control can also cause menstrual
bleeding to stop (22). Light bleeding shares many of the same causes and risk factor as
amenorrhea, including PCOS, extreme exercise, nutritional deficiencies, stress, and
hormonal birth control (25).
The reported prevalence of period pains among women of reproductive age varies
widely, ranging from 16% to 91% (26). Pain associated with menstruating is often due to
uterine muscle spasms and restricted blood flow (15). Risk factors for this type of pain
include age, high body mass index, menorrhagia, no history of pregnancy, depression,
and a family history of period pain (26). Painful periods can also be caused by
endometriosis, polyps, and fibroids (26).

History of Tear Gas and Pepper Spray
The tear gas agent CN was first developed during World War I (27). CS was
developed in 1928, CR in 1962, and OC in the 1970’s (27, 28). The use of chemical
agents, including tear gas, were banned for use in military conflicts by the Geneva
Protocol (1925) and the Chemical Weapons Convention (1993). The United States used
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tear gas the Vietnam War despite the Geneva Protocol (29). While banned in wartime,
tear gas and pepper spray were not banned for domestic use and were adopted by law
enforcement agencies (3, 27). CS and OC are currently the most common crowd control
chemical irritants used by law enforcement (27).
The federal government of the United States does not regulate crowd control
irritants, although a bill to do so was introduced by U.S. Senator Tim Kaine in May 2021
(30). Laws to regulate the use of crowd control irritants have passed in several states.
Specifically, the states of California, Oregon, and Washington have passed laws
restricting the use of tear gas, though the Washington law does not regulate the use of
pepper spray (31-33).
Concerns over unexpected effects of tear gas and pepper spray exposure among
protesters have been raised in recent decades, especially after large scale civilian
exposures in Israel in the 1980s and Bahrain in 2011 (29, 34). In both instances, there
were reports of increased miscarriages among exposed populations (29, 34). Concern was
great enough that in 2011, Chile temporarily banned the use tear gas during protests (29).
There is still a great deal of uncertainty as to whether tear gas and pepper spray have any
reproductive effects.
More recently, tear gas and pepper spray have been deployed against racial justice
demonstrators in cities such Louisville, Kentucky. The protests in Louisville began May
28, 2020 and were met with crowd control irritant chemical deployed by police on the
first day (35). The following June, the Louisville Metro Police updated their tear gas
policy so that the chief of police (or designee) would have to approve of the use of tear
gas before it was deployed (36). Protests continued for at least 365 consecutive days (34).
11

In August of 2020, American Civil Liberties Union of Kentucky filed a motion for a
restraining order to keep police officers from using tear gas against protesters. The
motion was denied (37). Restrictions on tear gas were proposed in September 2020 in an
ordinance to limit use of force by the police department, but were removed from the final
version citing a reduction in tear gas use by officers (38). It is unknown how many people
were exposed to tear gas during the Louisville protests.

Health Effects of Tear Gas and Pepper Spray
While the potential reproductive effects of tear gas and pepper spray are poorly
understood, their effects on eyes, the respiratory system, and skin are well-documented
(3). Heart effects have also been documented (3). The damaging effects of CS and CN
are believed to be a result of their ability to deactivate enzymes (39). CS and CN are both
SN2-alkylating agents and react with enzymes in areas such as sulfhydryl and thiol
groups (39). The deactivation of essential enzymes can cause damage in affected tissues
that persists after the exposure has ended (39). Short term effects of CS and CN, such as
pain and cough, result from the interaction with a type of transient receptor potential
(TRP) channel called TRPA1 (3). OC interacts with similar TRP channels known as
TRPV1 (3). TRP channels are present in nerves that are capable of sensing pain (3). Pain
and injury from the deployment of tear gas and pepper spray can also occur as a result of
carrier solvents in sprays, abrasion from powders, burns from incendiary devices, and
blunt force trauma from launched cannisters and projectile pellets (40).
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The eyes are one of the primary targets of tear gas and pepper spray. CS, CN, and
OC all cause tearing (lacrimation), pain, and involuntary blinking or closing of the eyes
(blepharospasm) (40, 41). CS exposure can result in conjunctivitis and in reduced vision
that resolves within a couple of days (10). CS is generally not associated with long term
eye effects (40). Aerosolized CN can cause corneal opacity for hours to months if it is not
quickly flushed out (40). CN powder has more potential to cause permanent injury and
has been associated with long-term corneal clouding, necrotizing keratitis, and optic
nerve damage (40). The powder form appears to be able to penetrate deeper into tissues
and can also cause injury due to its abrasive properties (40). OC exposure can cause
conjunctivitis, increase intraocular pressure, and transient vision loss (40, 41). Longerterm effects include corneal ulcers and necrosis (40). OC and CS are less likely than CN
to have long-term effects, but repeated exposure make long-term injury more likely (40).
The respiratory system is the other primary target of tear gas and pepper spray.
Acute effects of CS, CN, and OC include cough, shortness of breath, and runny nose, and
sore throat (2). While these effects are usually temporary and not life threatening, serious
reactions can occur in individuals with asthma and those who have become sensitized
through repeat exposures to tear gas and pepper spray (3). Potential serious reactions
include spasming and swelling of the airways, which can impair breathing, and in some
cases, lead to death (39). OC, in particular, is associated with pulmonary edema (3).
Long-term effects of tear gas and pepper spray include persistent cough, asthma, and
chronic bronchitis (3). CS exposure is associated with the development of respiratory
infections (3). Severe effects, including death, are more likely when tear gas or pepper
spray is deployed in an enclosed space (39).
13

The most common effect of tear gas and pepper spray on skin is a burning
sensation (2, 39). They can also cause blistering, rashes, and chemical burns (39). CN is
more likely to cause severe burns than CS or OC, though OC is more difficult to wash off
as it is an oil (39, 42). All three agents can cause long-term sensitization resulting in
contact dermatitis with repeat exposure, but CN is the most potent sensitizer (39).
Sensitization to OC can cause contact dermatitis after preparing or ingesting culinary
chili peppers (43).
Tear gas and pepper spray can also affect the cardiovascular system. CS, CN, and
OC all cause a transient rise in blood pressure (42). There is disagreement in the
published literature as to whether CS, CN, and OC trigger bradycardia, tachycardia, or
both (39, 42). In at least two cases, tear gas or pepper spray has been suspected in the
precipitation of myocardial infarction (40, 41). One involved CS exposure and the other
OC exposure (44, 45).

Previous Research
An area that has received little attention is the potential effects of tear gas and
pepper spray on the female reproductive system. This includes fertility, pregnancy
outcomes, and menstrual cycle characteristics. Only three original research articles and
an abstract were identified through PubMed and searches of the references in peerreviewed papers on tear gas and pepper spray (2, 46, 47). A non-peer-reviewed article in
preprint was also identified through a general internet search (48).

14

The earliest paper was published by Upshall in 1973 (46). In this study, pregnant
rats and rabbits were exposed to CS (as an aerosol or as an injection). The initial phase of
the aerosol study, pregnant rats were exposed to either 20 mg/m3 or silica dust for 5
minutes a day for 15 days. The dose-response phase included both rats and rabbits. Rats
were exposed on days 6 through 15 of pregnancy and rabbits were exposed on days 6
through 18 of pregnancy. Test animals were initially divided into two exposure
categories: 20 mg/m3 aerosolized CS and silica dust controls. In a later arm of the study,
animals were divided into four exposure categories to test for a dose response: 6 mg/m 3,
20 mg/m3, and 60 mg/m3 aerosolized CS, and silica dust exposure controls. Twenty-two
rats and 12 rabbits were assigned to each exposure group. Rats were euthanized at day 21
of pregnancy and rabbits at day 30 of pregnancy. These dates were selected as they are
one day before the expected dates of delivery. There was also an intraperitoneal injection
arm of the study in rats (46). The number of rat fetuses in each inhalation exposure group
ranged from 222 to 242 and the number of rabbit fetuses ranged from 45 to 79 fetuses. In
the initial CS versus control phase of the study, visible gross malformations, total number
of pregnancies, mean litter size, total number of fetuses, fetal loss, and fetal weight were
not significantly different. The pregnancy weight gain in the treated pregnant rats was
significantly decreased (by 22.9%) when compared to controls. In both rats and rabbits,
the following outcomes were not significantly different between exposures: visible gross
malformations, total number of pregnancies, mean litter size, total number of fetuses,
fetal loss, and pregnancy weight gain. There was a dose-response decrease in rat fetal
weight as CS dose increased (6 mg/m3: 7.6%, 20 mg/m3: 8.5%, and 60 mg/m3: 11.0%
decrease) (46).
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The injection study in the Upshall study was restricted to rats. Pregnant rats were
injected with either CS (20 mg/kg in polyethylene glycol 300) or with polyethylene
glycol (control) intraperitoneally on one day of pregnancy. The day of injection was day
6, 8, 9, 10, 12, or 14 of pregnancy. The rats were euthanized the day before expected
delivery. There were 8 to 18 pregnant rats per injection group, and 100 to 174 fetuses.
There were no significant differences in visible gross malformations, total number of
pregnancies, mean litter size, total number of fetuses, fetal loss, and pregnancy weight
gain between the groups. Mean fetal weight in the group injected with CS at day 12 was
8% lower than in controls. The fetal weights of the remaining exposure groups were not
significantly different (46).
In 1978, Chowdhury et al. published a study investigating whether CS exposure
was associated with histological thyroid changes in rats (49). The study included three
exposure groups of female rats with 10 rats per group. Rats in each group were given
intraperitoneal injections of either CS dissolved in olive oil at 10 mg/kg or 20 mg/kg, or
just olive oil (control). Injections were administered each day for ten days and the rats
were euthanized on day 11. The thyroid from each rat was fixed in Bouin’s fluid for
histological examination. Degeneration of the thyroid follicle was observed in both of the
CS groups. In the 10 mg/kg group the degeneration was mild and in the 20 mg/kg group
the degeneration was severe. The degeneration was believed to either be from a reduction
of thyroid stimulating hormone (THS) release from the pituitary or from direct damage to
the thyroid by the CS (49).
An abstract published in 2004 by McElhatton et al. examined CS exposure in
pregnant women and pregnancy outcomes (47). This study was a prospective case series
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that included 30 pregnant women. All of the women were exposed to CS; however, the
circumstances around the exposures were not reported. Approximately 63% of the
pregnant women experienced temporary acute symptoms after exposure to CS gas. One
neonate with malformation, one spontaneous abortion, and one elective abortion were
reported. The prevalence of these outcomes was not significantly different from the
general population (47).
Torgrimson-Ojerio et al. published a study in 2021 that looked at exposure to
general crowd-control irritants in Portland, Oregon and the associated short-term and
long-term symptoms (2). The data were collected through an online survey and that was
available from July 30, 2020 to August 20, 2020. One thousand six hundred fifty
participants provided menstrual health data. The survey included both quantitative and
qualitative questions. The main quantitative exposure variable was the number of days
that respondents were exposed to tear gas. Exposure was split into three categories for
analysis: 1 day, 2 to 4 days, and greater than or equal to 5 days. Outcomes were divided
into immediate physical health issues, delayed physical health issues, and psychological
health issues. The quantitative delayed health issues included menstrual cycle issues,
such as increased cramping, increased bleeding, increased clots, increased days of
bleeding, unusual bleeding, change in bleed color, decreased days of bleeding, breast
tenderness, and other. Associations between the exposure groups and menstrual outcomes
were analyzed using the Cochran-Armitage trend test. All of the menstrual outcomes,
except “other”, had significant positive associations with tear gas exposure. Answers to
the open-ended qualitative questions demonstrated that many respondents experienced
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early and unusually long menstrual bleeding. The authors suggest that tear gases may be
endocrine disruptors (2).
The article in preprint that was not peer-reviewed was published online in 2020
by Mahfud et al. (48). Yellow Vest protesters in France were invited to participate in an
online survey in February 2020, until the start of the SARS-CoV-2 pandemic in March
2020. Exposures fell into four categories: never, fewer than 5 exposures, 5 to 10
exposures, and greater than 10 exposures. General symptoms of CS tear gas exposure and
the presence of menstrual cycle symptoms were collected from 145 participants. Specific
menstrual cycle outcomes were not included as part of the questionnaire. Rather,
participants were asked to indicate whether menstrual cycle anomalies. Participants were
instructed to indicate whether symptoms were short-term or long-term. Correlation and
logistic regression models were also used to determine whether tear gas exposure was
associated with menstrual cycle abnormalities. Exposure number and general symptoms
of tear gas were correlated with abnormal menstrual cycles. In the logistic models,
exposures were associated with significantly higher odds of reporting menstrual
abnormalities of any duration, as well as long-term menstrual abnormalities. However,
the associations were no longer significant after adjusting for unspecified demographic
and health covariates (48).

Biological Mechanism
Tear gas and pepper spray primarily interact with the body through TRPA1 and
TRPV1 channels, respectively. While not extensively studied in humans, these channels
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have been found in the hypothalamus in rat and mouse models (50, 51). As study
published in 2020 by Surkin et al. provided evidence that stimulation of TRPV1 channels
may activate the hypothalamus-pituitary-gonadal axis in male rats, resulting in GnRH and
LH (52). In the human body, elevated levels of GnRH and LH are believed to be the
cause of many of the symptoms of PCOS, such as amenorrhea, oligomenorrhea,
menorrhagia, and metrorrhagia (15, 53, 54).
The first proposed mechanism by which tear gas (CS and CN) and pepper spray
(OC) influence menstrual cycle outcomes is illustrated in Figure 4. OC activates TRPV1
and CS and CN activate TRPA1. TRPV1 stimulates the hypothalamus to produce a
greater frequency of GnRH. TRPA1 activation is hypothesized to have similar effects as
TRPV1 in the hypothalamus. The increase in GnRH pulsatility (frequency of pulses)
signals the pituitary to release LH. Elevated levels of LH act on the ovaries by inhibiting
ovulation. In the absence of ovulation, menstrual cycle may be absent (amenorrhea) or
irregular (oligomenorrhea). The release of progesterone is depressed due to the lack of
ovulation, and the endometrium is allowed to continue to grow. The buildup of the
endometrium can lead to breakthrough bleeding (metrorrhagia), or in heavy and
prolonged bleeding (menorrhagia) and period pain (dysmenorrhea) should the menstrual
cycle resume.
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Figure 4: Tear Gas, Pepper Spray, and the Hypothalamus-Pituitary-Gonadal Axis

Tear gas, specifically CS, also been shown to result in damage the thyroid in rats,
as demonstrated by Chowdhury et al., though it was not clear whether the CS damaged
the thyroid directly or indirectly (through inhibition of TSH) (49). Based on this prior
research, the second proposed mechanism is illustrated in Figure 5. CS and CN cause
damage to the thyroid which reduces the production of T3. Low T3 levels inhibit
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ovulation and the support of the endometrium, which can lead to metrorrhagia,
oligomenorrhea, and amenorrhea.
Figure 5: Tear Gas and the Hypothalamus-Pituitary-Thyroid Axis

Conclusion
Menstrual disorders can have a significant negative impact on women’s overall
quality of life. Women with severe symptoms can experience fatigue, pain, psychological
distress, and missed days of school and work (55). It’s estimated that absence from work
and lower productivity due to menstrual disorders results in an annual loss of $12 to $36
21

billion in the United States (55). That loss does not include the medical bills that result
from women seeking treatment (55). Understanding the causes of menstrual orders, for
both prevention and treatment, is important for the quality of women’s lives and the
economic advancement of women and society. The study by Torgrimson-Ojerio et al.
provided evidence that exposure to tear gas may be associated with menstrual disorders
(2). Considering the exposure of large numbers of protesters in 2020 and 2021, further
understanding this association has become increasingly urgent.
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SPECIFIC AIMS AND HYPOTHESES
Specific Aim 1
Determine whether there is an association between the number of protests attended and
female reproductive health outcomes.
a. Determine whether there is an association between the number of reported
protests and the number of reported menstrual health outcomes.
Hypothesis: There will be a significant positive association between the number
of reported protests and the number of reported menstrual health outcomes.
b. Determine whether there is an association between the number of reported
protests and any menstrual health outcome factors that were identified through
exploratory factor analysis.
Hypothesis: There will be a significant positive association between the number
of reported protests and the reported menstrual health outcome factors.

Specific Aim 2
Determine whether there is an association between the number acute teargas effects and
female reproductive health outcomes.
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a. Determine whether there is an association between the composite score of
reported acute tear gas effects (eye, lung, skin, heart) and the number of reported
menstrual health outcomes.
Hypothesis: There will be a significant positive association between the number
of reported composite score of reported acute tear gas effects and the number of
reported menstrual health outcomes.
b. Determine whether there is an association between the composite score of
reported acute tear gas effects (eye, lung, skin, heart) and any identified menstrual
health outcome factors.
Hypothesis: There will be a significant positive association between the number
of reported composite score of reported acute tear gas effects and menstrual health
outcome factors.

Specific Aim 3
Determine whether there is an association between acute effects in any specific organ
system (eye, lung, heart, skin) and female reproductive health outcomes.
a. Determine whether there is an association between acute effects in any specific
organ system (eye, lung, skin, heart) and the number of reported menstrual health
outcomes.
Hypothesis: There will be a significant positive association between reported
acute tear gas effects in the eye, lung, skin, and heart and the number of reported
menstrual health outcomes.
24

b. Determine whether there is an association between acute effects in any specific
organ system (eye, lung, skin, heart) and any identified menstrual health outcome
factors.
Hypothesis: There will be a significant positive association between reported
acute tear gas effects in the eye, lung, skin, and heart and menstrual health
outcome factors.

Specific Aim 4
Determine whether there is an association between seeking medical care for acute effects
and female reproductive health outcomes.
a. Determine whether there is an association between seeking medical care for acute
effects and the number of reported menstrual health outcomes.
Hypothesis: There will be a significant positive association between seeking
medical care for acute effects and the number of reported menstrual health
outcomes.
b. Determine whether there is an association between seeking medical care for acute
effects and any identified menstrual health outcome factors.
Hypothesis: There will be a significant positive association between seeking
medical care for acute effects and menstrual health outcome factors.
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METHODS
Population
The target population of the study was individuals aged 18 year and older who
believed that they were exposed to tear gas in the years 2020 and 2021. To be included
for analyses for this dissertation, respondents had to identify as female, report their age as
less than 46 years, and have complete data for all covariates that were included in the
models.

Study Design
The data were drawn from the University of Louisville Investigation of Possible
Health Effects of Tear Gas Among Protestors in the U.S. Study, also known as the Tear
Gas Study. This was a cross-sectional study designed to determine whether self-reported
exposures to tear gas resulting from protests in 2020 and 2021 were associated with
short-term and long-term health outcomes, as well as whether pre-existing conditions
were associated with tear gas related health outcomes. The study was also intended to
report findings directly back to the community that contributed data through updates to
participants who indicated that they would like to be recontacted for this purpose. The
Tear Gas Study was approved by the Institutional Review Board of University of
Louisville, KY (IRB 20.0802).
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The initial questionnaire was retrospective, but the study was designed to also
include prospective follow-up questionnaires for participants who consented to be
recontacted. The questions included on the questionnaires were based on the literature on
tear gas exposure and health outcomes (2). Initial questions were drafted by researchers
and community members directly involved with the Tear Gas Study. A committee of
epidemiological and environmental researchers was also convened to review the drafted
questions and propose additional questions. The final version of the main questionnaire
(version 4) is included in Appendix A.
The Tear Gas Study originally targeted residents of Louisville, Kentucky who had
been exposed to tear gas during the 2020 racial justice demonstrations. The target
population was then expanded to residents of the United States who had been exposed to
tear gas during 2020 and 2021. Participants were recruited through social media
(Facebook and Twitter) posts and advertisements, as well as flyers distributed to
community partners. The study was also covered in several news outlets (56-58).
Individuals interested in participating were initially asked to send a message to the study
email address for a participant identification number and the link to the online
questionnaire. After the 236th participant, the requirements of emailing and acquiring a
participant identification number were eliminated. Direct links (hyperlinks and QR
codes) to the questionnaire were available on social media posts, the study website, and
flyers. Recruiting materials initially offered twenty-dollar gift cards to participants who
submitted a questionnaire. This was discontinued due to the high volume of blank and
identical questionnaires that were submitted. Criteria for eliminating potential duplicates
are discussed in further detail below.
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The electronic questionnaire was created and maintained on Research Electronic
Data Capture (REDCap), a secure, online platform for entering and storing data (59, 60).
The platform is compliant with the Health Insurance Portability and Accountability Act
of 1996 (HIPAA).Data could be downloaded in multiple formats, including as a commaseparated values (CSV) file or as a datafile for several statistical software packages. Each
questionnaire that was initiated was automatically assigned a record identification
number by REDCap. The questionnaire was preceded by a preamble that explained the
purpose of the Tear Gas Study and the type of questionnaire that would follow. The
preamble included the phone number of the primary investigator (PI) with instructions to
contact the PI if the participant had any questions about the study. Contact information
for the Human Subjects Protection Office and complaint hotline was also provided.
Participants could decide whether to continue with the questionnaire that followed the
preamble. The questionnaire included two screener questions: whether the participant
was 18 years of age or older and whether the participant was exposed to tear gas. A “no”
answer to either question ended the questionnaire. Participants were not able to view any
of the participant-level or aggregate data while on the REDCap site.

Exposure Assessment
The exposure of interest for this project was intensity of crowd control chemical
irritants, under the umbrella term “tear gas”. All participants reported being exposed to
tear gas. Participants were unlikely to know what kind of tear gas (CS or CN) that they
were exposed to and may not have been able to differentiate between tear gas and pepper
spray. The questionnaire used the term “tear gas” with the understanding that participants
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may refer to either true tear gas or pepper spray products and is used as such throughout
the study. The exposure was assessed three ways; each serves as an estimate of the extent
of tear gas exposure. The first was the number of protests attended, regardless of the
presence tear gas. Protests number options on the questionnaire included the following: 1,
2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, and >20. The second
method was a composite score of acute health effects of tear gas. These health effects
include eye (watering, burning/stinging, other), lung (coughing, burning, shortness of
breath, other), skin (burning, blistering, other), and heart (increased heart rate, irregular
heartbeat, chest pain, other). Participants were instructed to select all that applied.
Composite scores were computed by summing the number of “yes” responses for the 13
health effects (from: 0 - 14) and were treated as continuous variables. The third method
treated acute effects in each target organ system separately (eye, lung, skin, heart). These
were also composite scores (lung range and heart ranges: 0 - 4; eye and skin ranges: 0 - 3)
that were handled as continuous variables. The final analysis used seeking medical
treatment (yes/no) as an exposure, and determined whether seeking medical treatment for
acute symptoms of tear gas was associated with menstrual cycle outcomes.

Outcome Assessment
The outcome of interest was menstrual health. The outcome was assessed using a
composite score of all menstrual cycle outcomes on the questionnaire (light bleeding,
heavy bleeding, period pains, irregular cycles, long bleeding, short bleeding, short cycle,
and long cycle) after exposure to tear gas. Participants were instructed to select all that
applied. The composite score could range from 0 to 8 and was treated as a continuous
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variable. Exploratory factor analysis was performed to determine whether specific
outcomes were interrelated and should be split into factors with separate models. The
estimated factor scores provided an additional outcome measure of menstrual symptoms.

Statistical Analyses
To be included in the analyses, questionnaire records must have met the set
inclusion criteria. The survey collected data from male, female, and transgender/nonbinary participants, but only female-identified records were included this analysis
(n=103). Participants also had to self-identify as being 18 to 45 years of age. In the event
that records were submitted with timestamps within one minute of one another with
identical or nearly identical data, only one of the records was included in the analyses.
Duplicates were excluded. This was a quality control measure intended to eliminate serial
submissions by the same participants. One hundred three records were eligible for
analysis based on these criteria.
Descriptive statistics for covariates were calculated for each exposure proxy and
each outcome. Protest number (1 – 9, > 9) and seeking medical care (yes, no) were binary
variables and chi-square p-values were calculated for each characteristic. Nine was
chosen as the cutoff as the resulting groups were close in size (n = 34 and 36,
respectively). T-test p-values were calculated for characteristics by acute symptoms
score, acute symptoms in specific organ systems, menstrual cycle outcome score, factor 1
and factor 2 as these predictors and outcomes were continuous variables. The p-values
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presented for all the analyses in this dissertation are two-sided and were considered
statistically significant when less than 0.05.
Correlation calculations and t-tests were performed to examine the unadjusted
associations between exposures and outcomes. Multiple linear regression was used to
determine the relationships between the exposures and the outcomes, after adjusting for
covariates. Statistical analyses were conducted using Statistical Analysis Software (SAS)
Version 9.4 (61). Potential covariates were identified through published literature and
directed acyclic graphs (DAGs) [Figures 6-8].
Figure 6: Directed Acyclic Graph for Protest Number and Menstrual Cycle
Outcomes
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Figure 7: Directed Acyclic Graph for Acute Effects and Menstrual Cycle Outcomes

Figure 8: Directed Acyclic Graph for Medical Care for Acute Effects and Menstrual
Cycle Outcomes

Menstrual cycle outcomes were potentially correlated. Exploratory factor analyses
(EFA) were conducted to identify the factor structure of the outcomes in the
questionnaire. The number of factors was determined by reading a scree plot of
Eigenvalues for values greater than 1 [Figure 9]. Item factor loadings were examined
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using promax nonorthogonal rotation. Items that loaded well on a single factor, with a
rotated factor loading of greater than 0.6 in absolute value were assigned to that factor
[Table 5, Figure 10]. Factor scores were then generated using the regression method (62).
The resulting factor scores are normalized as standard deviations around a mean of zero.
Normalizing the scores to the same scale allows for comparison between the factors. The
identified factors were included as outcome variables in linear regression models for each
research aim.
Confounders were determined through the use of directed acyclic graphs [Figures
6-8]. Identified confounders were age, race, ethnicity, socio-economic status (SES)
indicators (education and income), and trying to conceive. Additional model-building
steps to evaluate the confounding, multicollinearity, precision, and interactions of the
confounders identified through DAGs were not conducted. Due to the small sample size,
the validity of the evaluations would have been questionable.
The final models included the main exposure (proxy for tear gas exposure) and
outcome variables; as well as the confounders identified through the DAGs. Different
proxies were not included together in models because of the interrelatedness detected
through Chi-square tests, t-tests, and correlation calculations (Appendix B). The flow
diagram for participant record inclusion is illustrated in Figure 9.
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Figure 9: Flow Diagram for Participant Records

Linear regression models with imputed data were also conducted as a sensitivity
analysis. Missing data on predictors and covariates were imputed for the 103 eligible
records. Twenty imputations were performed for each missing datapoint. Results from
the analyses with imputed data are in Appendix C.
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RESULTS
Descriptive Statistics
Between March 15 and September 23, 2021, 301 records (questionnaires) were
logged on REDCap. Of these, 103 were eligible to be included in the analysis based on
the previously outlined criteria (18 - 45 years of age, reported tear gas exposure, no
duplication of records, and female). The final analyses for each aim excluded records that
were missing data on the predictors and covariates specified for each model. The models
for Aim 1 included 70 records, Aims 2 and 3 included 71 records, and Aim 4 included 62
records [Figure 9].
Descriptive statistics were performed for the 103 eligible participants [Tables 14]. Forty percent reported Kentucky as their state of residence. All other reported states of
residence made up 6% or less of the sample. Fifty percent were aged 18 to 32, 54% were
white, 49% reported an income of $50,000 or higher, and 42% had graduated from
college. 27% sought medical care for acute symptoms of tear gas exposure and 21% were
trying to conceive. The majority of respondent either attended 1 to 2 protests (30%) or
greater than 20 protests (30%). The median acute symptom score was 5 (IQR = 0 - 8).
The median menstrual cycle outcome score (total number of 8 menstrual cycle
symptoms) was 1 (IQR = 0 - 2). Factor 1 had a median score of -0.59 (IQR = -0.75 0.75) and factor 2 had a median score of -0.57 (IQR = -0.57 - 0.50). Factor 1
(representing high severity symptoms) and factor 2 (representing milder symptoms) were
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normalized as standard deviations from the mean of 0. Descriptive statistics for eligible
records were stratified by protest number [Table 1]; acute symptom composite score, as
well as eye, lung, skin, and heart symptom scores [Table 2]; seeking medical care [Table
3]; and menstrual cycle, factor 1, and factor 2 scores [Table 4].
Table 1: Characteristics of Participants by Protest Number, n=101

Characteristic
Age (years)
18 - 32
33 - 45
Missing
Race
White
Other
Missing
Ethnicity
Hispanic
Non-Hispanic
Missing
Highest education
No undergraduate degree
Undergraduate degree
Missing
Income
≤ $49,999
≥ $50,000
Missing
Trying to conceive
No
Yes
Missing

1 - 9 Protests
N=54
N (%)
14 (35)
26 (65)
14

> 9 Protests
N=47
N (%)

Chisquare
p-value
0.0036

27 (68)
13 (33)
7
0.90

24 (55)
20 (45)
10

25 (53)
22 (47)
0

12 (24)
39 (76)
3

4 (11)
33 (89)
10

0.13

0.068
35 (66)
18 (34)
1

22 (48)
24 (52)
1

20 (38)
32 (62)
2

28 (64)
16 (36)
3

0.014

0.74
41 (82)
9 (18)
4
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33 (85)
6 (15)
8
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Characteristic
Age (years)
18 - 32
33 - 45
Missing
Race
White
Other
Missing
Ethnicity
Hispanic
Non-Hispanic
Missing
Highest education
No undergraduate degree
Undergraduate degree
Missing
Income
≤ $49,999
≥ $50,000
Missing
Positive COVID-19 Test
No
Yes
Missing
Trying to conceive
No
Yes
Missing

Mean±SD
7.20±2.59
5.27±3.32

5.58±2.79
5.51±4.23

5.00±3.83
5.66±3.52

4.22±4.23
6.02±2.59

6.31±3.22
3.40±3.71

6.35±3.00
4.86±4.20

5.56±3.70
5.07±2.55

n (%)
41 (50)
41 (50)
21
50 (54)
43 (46)
10
16 (18)
74 (82)
13
59 (58)
42 (42)
2
49 (51)
48 (49)
6
66 (83)
14 (18)
23
75 (83)
15 (17)
13

0.62

0.12

< 0.0001

0.016

0.50

0.93

t-test
p-value
0.0044

Total Acute
Symptoms

1.50±0.96
1.40±0.63

1.68±0.79
1.36±1.08

1.71±0.84
0.94±1.00

1.08±1.07
1.74±0.70

1.31±0.95
1.54±0.92

1.58±0.76
1.42±1.07

1.98±0.69
1.41±0.81

Mean±SD

Eye

0.68

0.19

< 0.0001

0.0008

0.38

0.40

t-test
p-value
0.0011

1.93±1.23
1.67±0.98

2.18±1.01
1.71±1.44

2.22±1.07
1.13±1.25

1.42±1.38
2.12±0.97

1.50±1.21
1.99±1.19

2.04±1.05
1.77±1.32

2.46±0.78
1.83±1.18

Mean±SD

0.0060

0.14

0.27

t-test
p-value
0.0052

0.43

0.15

< 0.0001

Lung

0.97±0.84
1.07±0.80

1.17±0.76
0.71±0.83

1.12±0.78
0.65±0.79

0.75±0.90
1.12±0.63

1.00±0.89
1.00±0.79

0.92±0.63
1.09±0.95

1.29±0.75
0.95±0.74

Mean±SD

0.30

t-test
p-value
0.041

0.68

0.049

0.0035

0.023

> 0.9999

Skin

1.15±1.24
0.93±0.96

1.32±1.14
1.07±1.33

1.24±1.25
0.69±0.99

0.97±1.26
1.05±1.03

1.19±1.17
1.14±1.21

1.04±1.07
1.23±1.31

0.53

0.48

0.017

0.73

0.87

0.44

t-test
Mean±SD p-value
0.14
1.46±1.25
1.07±1.10

Heart

Table 3: Characteristics of Participants by Seeking Medical Care for Acute Effects,
n=73

Characteristic
Age (years)
18 - 32
33 - 45
Missing
Race
White
Other
Ethnicity
Hispanic
Non-Hispanic
Missing
Highest education
No undergraduate degree
Undergraduate degree
Missing
Income
≤ $49,999
≥ $50,000
Missing
Trying to conceive
No
Yes
Missing

Medical Care No
n=52
n (%)

Medical Care Yes
n=21
n (%)

30 (58)
22 (42)
0

9 (45)
11 (55)
1

35 (67)
17 (33)

11 (52)
10 (48)

Chisquare
p-value
0.33

0.23

0.0060
5 (10)
44 (90)
3

8 (38)
13 (62)
0
0.082

19 (37)
32 (63)
1

12 (60)
8 (40)
1
0.90

29 (62)
18 (38)
5

12 (60)
8 (40)
1
0.025

44 (88)
6 (12)
2
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13 (65)
7 (35)
1
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Characteristic
Age (years)
18 - 32
33 - 45
Missing
Race
White
Other
Missing
Ethnicity
Hispanic
Non-Hispanic
Missing
Highest education
No undergraduate degree
Undergraduate degree
Missing
Income
≤ $49,999
≥ $50,000
Missing
Positive COVID-19 Test
No
Yes
Missing
Trying to conceive
No
Yes
Missing
2.24±2.50
1.35±2.19

2.25±2.29
1.66±2.35

1.12±2.11
2.29±2.32

2.12±2.52
0.92±1.71

2.42±2.54
0.29±0.61

1.88±2.47
1.20±2.34

50 (54)
43 (46)
10
16 (18)
74 (82)
13
59 (58)
42 (42)
2
49 (51)
48 (49)
6
66 (83)
14 (18)
23
75 (83)
15 (17)
13

41 (50)
41 (50)
21

n (%)

0.32

0.0028

0.0071

0.0099

0.36

0.073

Total Menstrual Cycle
Symptoms
t-test
p-value
Mean±SD
0.12
2.49±2.69
1.63±2.13

0.07±1.00
-0.09±0.86

0.29±1.04
-0.52±0.54

0.23±1.04
-0.31±0.81

-0.23±0.86
0.30±1.05

0.14±0.95
0.06±1.02

0.19±1.06
-0.05±0.93

0.33±1.04
0.04±1.00

Mean±SD

Factor 1

0.56

0.0064

0.0050

0.0068

0.77

0.24

t-test
p-value
0.20

-0.03±1.04
0.28±0.75

0.21±1.14
-0.30±0.55

-0.01±1.12
0.08±0.73

-0.14±0.89
0.15±1.05

0.57±1.08
-0.09±0.95

0.22±1.16
-0.12±0.82

0.27

0.11

0.75

0.14

0.017

0.12

Factor 2
t-test
p-value
Mean±SD
0.80
0.10±1.12
0.16±1.02

Participants who reported an income of at least $50,000 attended significantly
fewer protests and had significantly fewer total acute symptoms of tear gas, acute
symptoms in specific organ systems, total menstrual cycle symptoms, and factor 1 scores.
Having at least an undergraduate degree was positively associated with total acute
symptoms of tear gas, acute symptoms in specific organ systems (excluding heart), total
menstrual cycle symptoms, and factor 1 scores. Participants over the age of 32 reported a
significantly lower protest attendance; as well as fewer total acute symptoms and acute
symptoms of the eyes, lungs, and skin. Hispanic ethnicity was significantly associated
with higher factor 1 score and with seeking medical care for acute exposure. Participants
who were trying to conceive also reported more medical care seeking behavior.
Two factors were identified for inclusion in the linear regression models [Figure
10]. Long bleed, short bleed, heavy bleed, long cycle, irregular cycles, and period pain
loaded on factor 1. Short bleed, light bleed, and short cycle loaded on factor 2 [Table 5,
Figure 11]. Generally, factor 1 represented more severe menstrual symptoms, while
factor 2 represented milder symptoms, though the two factors were correlated (ρ = 0.504,
p < 0.0001). Together, factor 1 and factor two explain 89.9% of the variance in the
menstrual symptoms.
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Figure 10: Scree Plot of Eigenvalues

2 Factors

Factor number

Table 5: Rotated Factor Loadings
Factor Loadings
Cycle Outcome

Factor 1

Factor 2

Light bleed

0.14207

0.93922

Heavy bleed

0.93389

0.17817

Long bleed

0.93183

0.25749

Short bleed

0.62030

0.80062

Short cycle

0.40165

0.77963

Long cycle

0.78103

0.49616

Irregular cycles

0.87585

0.37628

Period pain

0.82730

0.45100
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Figure 11: Menstrual Cycle Outcomes Loaded on Two Factors

e = error

Unadjusted associations between the tear gas exposure proxies and the outcomes
were examined through the use of correlation coefficients and t-test p-values, depending
on whether the proxy was a continuous or binary variable [Tables 6 & 7]. Total acute
symptom score, and acute symptoms of the eye, lung, skin, and heart were correlated
with total menstrual cycle symptom score and factor 1, but only heart symptoms were
correlated with factor 2. Protest attendance had significant positive associations with
menstrual cycle symptom score, factor 1, and factor 2. Seeking medical care for tear gas
exposure had significant inverse associations with menstrual cycle symptoms score, and
factor 1.
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Table 6: Correlation Coefficients (ρ) for Acute Symptoms of Tear Gas and
Menstrual Cycle Outcomes, n=103
Total Cycle
Symptoms

Factor 1

Factor 2

Total Acute
Symptoms

0.3404**

0.3563**

0.1914

Eye

0.3045*

0.4047***

0.1451

Lung

0.3703**

0.4088***

0.1714

Skin

0.2462*

0.2197*

0.1310

Heart

0.2572*

0.2007*

0.2114*

* p-value < 0.05
** p-value < 0.001
*** p-value < 0.0001
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Tear Gas
Proxy
Protests
1-9
>9
Medical
Care
No
Yes
52 (71)
21 (29)

54 (53)
47 (47)

n (%)

2.60±2.61
1.00±1.95

0.014

Total Menstrual Cycle
Symptoms
t-test
p-value
Mean±SD
< 0.0001
0.67±1.20
2.68±2.70
0.53±1.03
-0.52±0.58

-0.47±0.62
0.52±1.05

Mean±SD

0.0003

t-test
p-value
< 0.0001

Factor 1

0.15±1.13
0.24±1.06

0.75

Factor 2
t-test
p-value
Mean±SD
0.046
-0.20±0.72
0.19±1.17

Models and Variable Coding
Twenty-one linear regression models were implemented in the investigation of the
specific aims [Table 8]. Beta coefficients and 95% confidence intervals were calculated
for protest number, acute symptom score, acute eye score, acute lung score, acute skin
score, acute heart score, and seeking medical care according to the model for the
particular aim. Outcome variables were menstrual cycle outcome score, normalized factor
1 score, and normalized factor 2 score. The definitions and methods of handling for each
variable included in the models are included in Table 9.
Table 8: Final Linear Models
Aim 1
Model 1: Factor 1 = β0 + β1*Protest Number + β2*Age + β3*Race + β4*Ethnicity + β5*Education
+ β6*Income + β7*Trying to Conceive
Model 2: Factor 2 = β0 + β1*Protest Number + β2*Age + β3*Race + β4*Ethnicity + β5*Education
+ β6*Income + β7*Trying to Conceive
Model 3: Cycle Score = β0 + β1*Protest Number + β2*Age + β3*Race + β4*Ethnicity +
β5*Education + β6*Income + β7*Trying to Conceive
Aim 2
Model 4: Factor 1 = β0 + β1*Acute Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 5: Factor 2 = β0 + β1*Acute Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 6: Cycle Score = β0 + β1*Acute Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Aim 3 (Eye)
Model 7: Factor 1 = β0 + β1*Eye Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 8: Factor 2 = β0 + β1*Eye Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 9: Cycle Score = β0 + β1*Eye Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Aim 3 (Lung)
Model 10: Factor 1 = β0 + β1*Lung Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
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Model 11: Factor 2 = β0 + β1*Lung Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 12: Cycle Score = β0 + β1*Lung Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education
+ β6*Income + β7*Trying to Conceive
Aim 3 (Skin)
Model 13: Factor 1 = β0 + β1*Skin Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 14: Factor 2 = β0 + β1*Skin Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 15: Cycle Score = β0 + β1*Skin Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Aim 3 (Heart)
Model 16: Factor 1 = β0 + β1*Heart Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 17: Factor 2 = β0 + β1*Heart Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 18: Cycle Score = β0 + β1*Heart Score + β2*Age + β3*Race + β4*Ethnicity + β5*Education
+ β6*Income + β7*Trying to Conceive
Aim 4
Model 19: Factor 1 = β0 + β1*Medical Care + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 20: Factor 2 = β0 + β1*Medical Care + β2*Age + β3*Race + β4*Ethnicity + β5*Education +
β6*Income + β7*Trying to Conceive
Model 21: Cycle Score = β0 + β1*Medical Care + β2*Age + β3*Race + β4*Ethnicity +
β5*Education + β6*Income + β7*Trying to Conceive

Table 9: Definitions for Model Variables
Variable

Definition

Age
18 - 32 years (reference)
33 - 45 years
Race
White (reference)
Other
Ethnicity
Hispanic
Non-Hispanic (reference)
Education
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No undergraduate degree (reference)
Undergraduate degree
Income
≤ $49,999 (reference)
≥ $50,000
Trying to Conceive
Yes
No (reference)
Protest Number
1 - 9 (reference)
>9
Acute Symptom Score
Continuous (0 - 14)
Eye Score
Continuous (0 - 3)
Lung Score
Continuous (0 - 4)
Skin Score
Continuous (0 - 3)
Heart Score
Continuous (0 - 4)
Sought Medical Care
Yes
No (reference)
Menstrual Cycle Score
Continuous (0 - 8)
Factor 1 Score
Continuous (-1.32 - 2.57)
Factor 2 Score
Continuous (-1.71 - 3.59)

Aim 1: Protest Number
Three models were run for Aim 1. Protest number was the predictor of interest.
Seventy records were included in the models. Compared to the reference of 1 to 9
protests, attending greater than 9 protests was significantly associated with higher
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menstrual cycle outcome scores and factor 1 [Table 10]. The only covariate that had a
significant effect was ethnicity. In model 3, Hispanic ethnicity was associated with higher
menstrual cycle outcome scores than non-Hispanic ethnicity.
Table 10: Multivariable Linear Models for Protest Number and Menstrual Cycle
Outcomes
Number of protests attended
n = 70

1-9
>9

βa
(95% CI)a
Factor 1 (Model 1)
38 (54)
0.000
Reference
32 (46)
1.219
(0.788, 1.650)

<0.0001

1-9
>9

Factor 2 (Model 2)
38 (54)
0.000
Reference
32 (46)
0.462
(-0.050, 0.974)

0.082

1-9
>9

Cycle Score (Model 3)
38 (54)
0.000
Reference
32 (46)
2.116
(1.120, 3.112)

<0.0001

Protests

a

n (%)

p-value

Adjusted for age, race, ethnicity, education, income, and trying to conceive.

Aim 2: Acute Symptoms of Tear Gas
The analyses for Aim 2 included three models in which acute tear gas exposure
symptom score was the predictor. Seventy-one records contributed data to the models.
Acute symptom score had non-significant positive associations with menstrual cycle
outcome score, factor 1 score, and factor 2 score [Table 11]. Education was significantly
positively associated with cycle score.
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Table 11: Multivariable Linear Models for Acute Symptoms of Tear Gas Exposure
and Menstrual Cycle Outcomes
Acute symptoms score
n = 71
βa
0.004

(95% CI)a
Factor 1 (Model 4)
(-0.078, 0.085)

0.018

Factor 2 (Model 5)
(-0.062, 0.099)

0.66

0.027

Cycle Score (Model 6)
(-0.147, 0.200)

0.76

p-value
0.93

a

Adjusted for age, race, ethnicity, education, income,
and trying to conceive.

Aim 3: Acute Symptoms in Specific Organ Systems
Aim 3 examined acute scores for eye, lung, skin, and heart symptoms as separate
predictors. Twelve models were run with data from 71 records. All associations with the
outcomes of interest were non-significant. Eye, lung, skin, and heart scores had positive
associations with menstrual cycle score and factor 2 score. Skin and heart scores had
inverse associations with factor 1 score, while the associations were positive for eye and
lung scores [Table 12]. Education had a significant positive associated with cycle score
for each organ system.
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Table 12: Multivariable Linear Models for Specific Acute Symptoms of Tear Gas
Exposure and Menstrual Cycle Outcomes
Specific acute symptoms
n = 71
Symptom
Eye

βa

(95% CI)a

p-value

0.156

Factor 1 (Model 7)
(-0.157, 0.469)

0.33

0.057

Factor 2 (Model 8)
(-0.256, 0.370)

0.72

Cycle Score (Model 9)
0.048
(-0.626, 0.722)
0.89
Lung
0.081

Factor 1 (Model 10)
(-0.158, 0.319)

0.51

0.021

Factor 2 (Model 11)
(-0.216, 0.259)

0.86

Cycle Score (Model 12)
0.088
(-0.423, 0.599)
0.74
Skin
Factor 1 (Model 13)
-0.072
(-0.401, 0.256)

0.67

Factor 2 (Model 14)
(-0.293, 0.360)

0.84

0.033

Cycle Score (Model 15)
0.084
(-0.619, 0.787)
0.82

Heart

Factor 1 (Model 16)
-0.077
(-0.285, 0.131)
Factor 2 (Model 17)
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0.47

0.066

(-0.141, 0.273)

0.53

Cycle Score (Model 18)
0.056
(-0.391, 0.502)
0.81
a

Adjusted for age, race, ethnicity, education, income, and trying to
conceive.

Aim 4: Medical Care for Acute Symptoms
The main predictor for Aim 4 was seeking medical treatment for acute tear gas
symptoms. Three models were run with the records from 62 participants. Medical
treatment had a significant inverse association with factor 1. The associations were nonsignificantly positive for factor 2 score, and non-significantly inverse for menstrual cycle
outcome score [Table 13]. None of the covariates were significantly associated with
menstrual cycle outcomes.
Table 13: Multivariable Linear Models for Seeking Medical Attention for Acute
Symptoms of Tear Gas Exposure and Menstrual Cycle Outcomes
Sought medical care for acute effects
n = 62
Medical
care

a

No
Yes

βa
(95% CI)
Factor 1 (Model 19)
42 (68)
0.000
Reference
20 (32)
-0.952
(-1.563, -0.340)

No
Yes

Factor 2 (Model 20)
42 (68)
0.000
Reference
20 (32)
0.190
(-0.489, 0.870)

0.59

No
Yes

Cycle Score (Model 21)
42 (68)
0.000
Reference
20 (32)
-0.987
(-2.420, 0.447)

0.18

n (%)

p-value

0.0035

Adjusted for age, race, ethnicity, education, income, and trying to conceive.
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Imputed Models
Each model was run again with data from the multiple imputation. These models
each included the full eligible sample of 103. The significant associations between protest
number and factor 1 (model 1), protest number and total menstrual cycle symptoms
(model 3), and seeking medical care and factor 1 (model 19) held. Significant positive
associations with imputed data that had not been seen in the unimputed models were
between protest number and factor 2 (model 2), total acute symptoms and total menstrual
cycle symptoms (model 6), eye symptoms and factor 1 (model 7), and lung symptoms
with both factor 1 and total menstrual cycle symptoms (models 10 & 12). The only
significant inverse association in the imputed models that was not in the unimputed
models was between seeking medical for acute symptoms of tear gas and total menstrual
cycle outcomes (model 21). Tables for the imputed data analyses are in Appendix C.
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DISCUSSION
The purpose of this study was to investigate whether exposure to tear gas during
the racial justice protests was associated with menstrual cycle characteristics or
abnormalities. The hypothesis was that tear gas exposure, as estimated by the number of
protests attended, number of acute tear gas symptoms, tear gas symptoms of specific
organ systems (eye, lung, skin, and heart), and seeking medical care for acute tear gas
symptoms would be significantly associated with menstrual cycle. The number of
protests attended, but not the other measures of tear gas exposure, was significantly and
positively associated with two measures of menstrual cycle characteristics (the number of
menstrual cycle symptoms, and factor 1 score). Seeking medical treatment for tear gas
exposure had significant inverse relationship with factor 1 score.

Protest Number
Protest number was a main tear gas exposure proxy of interest. Participants who
reported attending more protests (> 9) reported statistically higher menstrual cycle
outcomes scores and factor 1 scores. Factor 1 generally included more intense menstrual
cycle outcomes (heavy bleed, long bleed, short bleed, long cycle, irregular cycles, and
period pain), while the menstrual outcomes included in factor 2 were generally milder
(light bleed, short bleed, and short cycle). However, there was a significant positive
association between protest attendance and factor 2 in the larger imputed dataset. These
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results generally support the hypothesis that protest number would have a significant
positive association with menstrual cycle outcomes. The association may be reflecting
protest number as an appropriate proxy for tear gas, as expected. If this is the case, the
pathway from protest number to menstrual cycle outcomes should go through tear gas
exposure [Figure 6]. The association may also be due to unidentified confounders or
alternative pathways. These possibilities will be explored in more detail below.

Acute Symptoms
Acute symptoms, both as a composite score and as symptoms of specific organ
systems, were not significantly associated with menstrual cycle outcomes. This may
indicate that acute symptoms are poor proxies for estimating tear gas exposure, and that
the frequency of tear gas exposure might be a better proxy for overall tear gas exposure,
as demonstrated by the significant association between number of tear gas exposures and
menstrual outcomes shown in the supplementary analyses. It is also possible that tear gas
is able to impact the menstrual cycle in doses that are too low to produce the acute
symptoms included in the questionnaire. Analyses of acute symptoms would, then, be
unable to differentiate between exposures that were above and below the threshold for
menstrual cycle symptoms to manifest. Based on available published literature, there
does not appear to be any research on the minimum dose required for menstrual cycle
effects.

Medical Care
54

Seeking medical care for tear gas acute symptoms of tear gas exposure had a
significant inverse association with factor 1, but non-significant associations with factor 2
and menstrual cycle outcomes. Per the stated hypotheses, medical care seeking behavior
was expected to be positively associated with menstrual cycle symptoms, factor 1, and
factor 2. Seeking medical care was intended to be a proxy for tear gas exposure, in which
higher exposure would lead more individuals to seek treatment. A possible explanation
for the inverse association seen with factor 1 is that seeking (and receiving) medical
treatment for tear gas exposure was not a proxy for exposure, but an effect modifier.
Medical treatment may have interrupted the processes that lead to factor 1 outcomes, but
not factor 2 outcomes. Seeking medical care is also correlated with overall self-care;
individuals who are more thoughtful and active about their health may have also taken
other measures to mitigate the effect of tear gas exposure (e.g., changing clothes or
showering after exposure). Total menstrual cycle outcomes include those of both factor 1
and factor 2, so the effect of medical treatment may have been diluted. In the imputed
models, the associations between seeking medical treatment and factor 1 was stronger
(smaller 95% confidence intervals and p-values), which may have contributed to the
significant inverse association between medical care and total menstrual cycle outcomes.

Biological Mechanisms
Two potential biological mechanisms to explain how tear gas may affect
menstrual cycle outcomes were proposed in Figures 4 and 5 and were incorporated in the
proposed hypotheses. In the first pathway, TRPV1 and TRPA1 receptors in the
hypothalamus are activated by OR, CS, and CN (50, 51). The overstimulation of the
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GnRH release leads to anovulation and abnormal menstrual cycle outcomes (53). In the
second pathway, CS and CN cause damage to the thyroid, reducing the production of T3,
which leads to altered menstrual cycles (13-15, 49).
There is the possibility that the association between protest number and menstrual
cycle scores was not a result of the tear gas exposure, but of the stress of the protests
themselves [Figure 12]. Previous research has provided evidence for an association
between stress and abnormal menstrual cycle outcomes. For example, Gordley et al.
published a study in 2000 that demonstrated a link between acute stress from life events
and menstrual cycle outcomes, such as period pain, long or heavy bleeding, and altered
cycle length (18). Anovulation has also been linked to stress and can present as a long
menstrual cycle (39). It has been hypothesized that the glucocorticoids released as part of
the stress response may disrupt hormone release by the pituitary and ovaries, thus altering
the menstrual cycle (5). The addition of a variable measuring stress within the models, as
well as a main predictor, may shed some light on whether stress affects the association of
tear gas exposure and menstrual cycle outcomes. However, data on stress was only
collected for 32 of the 103 eligible participants and was not included in these analyses.
Figure 12: Alternate Pathway Through Stress from Protest Number to Menstrual
Cycle Outcomes
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Published Literature
The results from these analyses in which protest number was used as a proxy for
tear gas exposure are in agreement with currently available literature on tear gas exposure
and menstrual cycle outcomes (2, 48). Torgrimson-Ojerio et al. found the number of tear
gas exposures to be significantly associated with cycle outcomes, such as clots, cramping,
changes in bleed length and color, and a lack of bleeding (2). Mahfud et al. reported tear
gas exposure number to have a significant association with increased reporting of total
abnormal menstrual cycle outcomes and long-term abnormal cycle outcomes before
adjusting for covariates. General symptoms of tear gas exposure were correlated with
menstrual cycle outcomes in the Mahfud et al. study; however, they were not significant
predictors in the current analyses. Differences may have been due to the Mahfud et al.
study analyzing a larger sample size and focusing specifically on CS gas, whereas the
current analyses likely included a mixture of crowd-control agents (48).

Implications for Public Health
In the dataset for this study, attending more than 9 protests was positively
associated with severe menstrual outcomes, while medical care for tear gas exposure had
an inverse association. These results could be used to inform members of the public who
are interested in attending protests on measures to reduce severe menstrual outcomes
after exposure to crowd control irritants. These measures include attending fewer protests
and seeking medical care in the event of exposure to tear gas or pepper spray. Medical
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treatment for tear gas and pepper spray includes decontamination, and information on
effective decontamination techniques need to be made widely available (3, 39).
On the policy side of public health, this study adds to the body of research that
indicates that crowd control irritants are not benign and can have short-term and longterm health effects that range from relatively mild to very serious (39). Tear gas and
pepper spray are known to cause chemical burns, blindness, and respiratory failure (39,
40). There is mounting evidence they can also have reproductive effects (2, 46-48).
Regulations at the national, state, and local levels are needed to limit the use of crowd
control irritants to extreme cases, such as violent riots. Steps have already been taken in
this direction, such as the previously mentioned laws passed in California, Oregon, and
Washington (31-33). Some of these laws do not include limitations on the use of pepper
spray (OC) with the limits on tear gas (33). While this study was not able to distinguish
between tear gas and pepper spray, previous research has shown that pepper spray can
also have severe health outcomes (including fatal lung edema) (3). The existing data do
not appear to support regulating pepper spray differently from tear gas (3, 39).
Any steps to reduce the use of crowd control irritants by law enforcement
agencies should include educating law enforcement agents on the proper use of tear gas
and pepper spray, the potential health outcomes for civilians and law enforcement agents
who are exposed, situations in which severe health outcomes are more likely (such as
deploying crowd control irritants in enclosed spaces), and decontamination methods to
avoid contaminating the homes and families of law enforcement agents (3). It should be
stressed that tear gas and pepper spray are not benign and should not be used unless
absolutely necessary.
58

Limitations
There are several potential limitations to this study. There may be residual
confounding from variables that were not identified through literature and DAGs, or that
were not collected in the questionnaire. For example, there may be unaccounted for
variables that make participants both more likely to be exposed to tear gas and more
likely to experience the menstrual outcomes of interest. An individual’s occupation could
influence both their protest attendance and menstrual health. Some individuals may have
underlying conditions that predispose them to both acute symptoms after tear gas
exposure and menstrual disorders. A person who is willing to seek medical care for acute
tear gas exposure may have other health habits that are associated with fewer menstrual
cycle disturbances. These could result in spurious associations between the predictors and
the outcomes. Residual confounding could also result from the dichotomous coding of
the covariates included in the models.
This study may also be subject to selection bias inherent to studies in which
participants are self-selected. Individuals who experienced more severe tear gas exposure
symptoms may be more motivated to participate in the study. This could result selection
bias if these same individuals were also more likely to experience menstrual cycle
disturbances, apart from those being caused by tear gas exposure. Possible sources of
information bias include the reliance on self-reported data, which may not be as accurate
as more objective data collection methods. The data were also collected retrospectively,
which introduces the possibility of recall bias. Participants who experienced more of the
menstrual cycle outcomes may be more likely to recall more severe tear gas exposure
than if they had not experienced those outcomes.
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Another limitation is that the study is unable to determine exactly what type(s) of
chemical irritant each participant was exposed to and at what dose. Participants may not
have been able to distinguish between tear gas and pepper spray, and there are different
formulations of these crowd control agents. Collecting data on individual exposures
through personal monitors was not feasible; thus only proxy measures of exposure were
available (protest number, acute exposure symptoms, and exposure number). Therefore,
the study was unable to determine which chemical agents at which concentration are
responsible for any associations between exposure and menstrual cycle issues that may be
identified. However, the data do reflect real world exposures experienced by protesters.
Number of protests attended was used as a proxy for tear gas exposure (as were
acute symptoms and seeking medical care) because exposure could not be measured
directly through personal air monitoring units in this study. Wrist bands that pick up
environmental chemicals have been developed, by they are not currently designed to
capture tear gas and pepper spray (63). Laboratory tests to identify crowd control irritants
post exposure are also generally unavailable (27). The question of how many times
participants believed that they were exposed to tear gas was added later to questionnaire.
Analyses of the 58 eligible participants who provided data on exposure number showed
similar results to protest number [Appendix D]. The binary protest number and exposure
number were also directly associated with one another (Chi-square p < 0.0001). These
results indicate that protest number is a reasonable proxy for tear gas exposure number.
The models also included small sample sizes, which may have impacted whether
they were sufficiently powered to detect significant outcomes. A post hoc power
exploration is included in Appendix E.
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A limitation specific to the exploratory factor analyses was the cross-loading of
short bleed on factor 1 and factor 2. Ideally, no item (symptom) would load strongly on
more than one item. Doing so indicates that the two factors poorly present short bleed. A
different non-orthogonal rotation could potentially resolve the cross-loading.

Strengths
One strength of this study is that it collected data on a variety of menstrual cycle
outcomes. This allowed for the examination of different ways that menstrual cycles can
be altered and to determine which were potentially related (in that they had common
underlying processes). Relatedness of the outcomes was determined through the use of
EFA, which is another strength of the study. Identifying factors and including them in
separate models reduced the model dimensionality.
Multiple proxies for tear gas exposure were modeled and compared to exposure
number. This demonstrated that protest number may be a good proxy for tear gas
exposure, but that acute symptoms and seeking medical care may not. The inclusion of
medical care also indicated that treatment for acute symptoms may be important for
preventing menstrual cycle outcomes, which could be of interest from a public health
standpoint.
This study contributes data to an area of public health (tear gas and menstrual
health outcomes) that has been the subject of little research. This work provides further
evidence that exposure to tear gas is associated with menstrual cycle outcomes. Data on
tear gas and health outcomes is of importance to policy makers, medical providers, and
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individuals who have been exposed to tear gas or who may be exposed in future
demonstrations.

Suggestions for Future Research
While the current study demonstrated an association between tear gas and
menstrual cycle outcomes, it is uncertain which specific tear gas agents are implicated.
Future research is needed on specific agents, such as OC, CS, and CN. It is also important
to understand which agents are and were being used in different areas of the United
States. This information would give protesters some idea of what specifically they were
exposed to. The development of inexpensive and easy to use personal monitors that could
be employed to analyze exposures of individuals would be an important tool when trying
to answer this question.
The results of the study indicate that seeking medical treatment for tear gas
exposure is associated with lower factor 1 (severe menstrual cycle symptoms) score.
Research on the effects of medical treatment is needed, including whether specific
interventions are more protective. Data on different interventions would help inform
medical professionals who may be treating exposed individuals. For example, are
immediate eye flushing and skin decontamination both important to preventing menstrual
disturbances? Do the formulations of cleaning solutions impact menstrual cycle
outcomes? Is there an optimal time frame for treatment for acute tear gas symptoms?
Research on these questions could inform best practices for reducing harm to patients
who have been exposed to crowd control irritants.
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Research is also needed on the duration of menstrual cycle disturbances after
exposure to tear gas. Long-term adverse menstrual changes could negatively impact
quality of life and financial stability of affected individuals (55). There is also the
question of whether there are long-term consequences as far as the ability of affected
individuals to achieve pregnancy and carry to term. McElhatton et al. conducted a study
with 30 women who were exposed to CS during pregnancy, in which adverse outcomes
(malformations and pregnancy loss) were not significantly different from the general
population (47). However, no studies were identified that examined fertility and
pregnancy in individuals who had been exposed to tear gas prior to conception. Data on
long-term reproductive outcomes could be important to individuals who have been
exposed (or who plan to participate in activities that may include exposure) and wish to
become pregnant in the future.
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CONCLUSION
The purpose of this study was to determine whether protest-related tear gas
exposure was associated with menstrual cycle disturbances. The results indicate that there
is a positive relationship between tear gas exposure and menstrual cycle symptoms:
participants who reported higher tear gas exposures also tended to report more menstrual
cycle symptoms. The study also found that seeking medical care for acute symptoms of
tear gas exposure may be protective. These results add to a small, growing body of
literature investigating health outcomes of tear gas exposure that have previously gone
undocumented. Tear gas exposure affects not only the nervous, cardiovascular, and
integumentary systems, but may cause hormonal disturbances which then alter
reproductive function. Future research is needed to better define the role of other
confounding variables (such as stress); examine the duration of menstrual cycle outcomes
post-exposure; determine the importance of seeking medical treatment for acute tear gas
exposure and whether it can mitigate adverse reproductive health outcomes; and evaluate
the potential for long-term fertility and pregnancy complications.
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Figure 13: Tear Gas Health Questionnaire, Version 4
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Table 14: Seeking Medical Care for Tear Gas Exposure by Protest Number, n=71
Protests
Medical
Care

1-9
n (%)

>9
n (%)

No
Yes

13 (28)
33 (72)

17 (94)
1 (6)

Chisquare
p-value
0.017

Table 15: Correlation Coefficients (ρ) for Acute Symptoms of Tear Gas, n=103
Total Acute
Symptoms

Eye

Lung

Skin

Total Acute
Symptoms

1

Eye

0.874*

1

Lung

0.934*

0.858*

1

Skin

0.885*

0.736*

0.741*

1

Heart

0.826*

0.507*

0.660*

0.704*

*p-value < 0.0001
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Heart

1
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Protests
1-9
>9
Medical Care
No
Yes

52 (71)
21 (29)

54 (53)
47 (47)

n (%)

Total Acute
Symptoms
t-test
Mean±SD p-value
0.039
4.22±3.88
5.74±3.37
0.48
6.73±2.41
7.19±2.69
Lung
t-test
Mean±SD p-value
0.0007
1.31±1.26
2.15±1.12
0.037
2.48±0.75
2.05±0.86

Eye
t-test
Mean±SD p-value
<0.0001
1.00±0.89
1.74±0.94
0.028
1.96±0.63
1.62±0.50

1.10±0.72
1.52±0.51

0.81±0.80
0.96±0.81

Mean±SD

Skin

0.016

t-test
p-value
0.38

1.19±1.10
2.00±1.14

1.09±1.23
0.89±1.11

Mean±SD

0.0065

t-test
p-value
0.40

Heart
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Table 17: Pattern of Missing Data, n=103
Group

Age Race

Ethnicity

Variable
Trying to
Education
Conceive

Income

Protests

Medical
Care

Frequency

Percent

1

X

X

X

X

X

X

X

X

61

59.2

2

X

X

X

X

X

X

X

.

9

8.7

3

X

X

X

X

X

X

.

X

1

1.0

4

X

X

X

X

X

.

X

X

4

3.9

5

X

X

X

X

.

X

X

X

1

1.0

6

X

X

X

X

.

.

.

X

1

1.0

7

X

X

X

.

X

X

X

X

1

1.0

8

X

X

.

X

X

X

X

X

3

2.9

9

X

X

.

X

X

X

X

.

1

1.0

10

.

X

X

X

.

X

X

.

1

1.0

11

.

X

X

.

.

.

X

X

1

1.0

12

.

X

.

X

.

X

X

.

9

8.7

13

.

.

X

X

X

X

X

.

10

9.7

X = data present
. = data missing

Table 18: Multivariable Linear Models for Protest Number and Menstrual Cycle
Outcomes with Imputed Data
Number of protests attended
n = 103

1-9
>9

βa
(95% CI)a
Factor 1 (Model 1)
0.000
Reference
0.924
(0.516, 1.332)

<0.0001

1-9
>9

Factor 2 (Model 2)
0.000
Reference
0.516
(0.078, 0.954)

0.021

1-9
>9

Cycle Score (Model 3)
0.000
Reference
1.892
(0.945, 2.840)

<0.0001

Protests

a

p-value

Adjusted for age, race, ethnicity, education, income, and trying to
conceive.
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Table 19: Multivariable Linear Models for Acute Symptoms of Tear Gas Exposure
and Menstrual Cycle Outcomes with Imputed Data
Acute symptoms score
n = 103
βa
0.063

(95% CI)a
Factor 1 (Model 4)
(0.000, 0.126)

0.054

Factor 2 (Model 5)
(-0.008, 0.116)

0.147

p-value
0.052

0.090

Cycle Score (Model 6)
(0.003, 0.292)
0.046

a

Adjusted for age, race, ethnicity, education, income,
and trying to conceive.

Table 20: Multivariable Linear Models for Specific Acute Symptoms of Tear Gas
Exposure and Menstrual Cycle Outcomes with Imputed Data
Specific acute symptoms
n = 103
Symptom
Eye

βa

(95% CI)a

p-value

0.295

Factor 1 (Model 7)
(0.061, 0.528)

0.013

0.149

Factor 2 (Model 8)
(-0.099, 0.394)

0.23

Cycle Score (Model 9)
0.401
(-0.164, 0.966)
0.16
Lung
0.235

Factor 1 (Model 10)
(0.049, 0.422)
0.014

0.152

Factor 2 (Model 11)
(-0.042, 0.346)
88

0.12

0.488

Cycle Score (Model 12)
(0.039, 0.938)
0.033

Skin
0.134

Factor 1 (Model 13)
(-0.137, 0.406)

0.33

0.151

Factor 2 (Model 14)
(-0.118, 0.421)

0.27

Cycle Score (Model 15)
0.482
(-0.133, 1.110)
0.12

Heart
0.110

Factor 1 (Model 16)
(-0.078, 0.297)

0.172

Factor 2 (Model 17)
(-0.005, 0.348)
0.057

0.25

Cycle Score (Model 18)
0.388
(-0.022, 0.798)
0.064
a

Adjusted for age, race, ethnicity, education, income, and trying to
conceive.
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Table 21: Multivariable Linear Models for Seeking Medical Attention for Acute
Symptoms of Tear Gas Exposure and Menstrual Cycle Outcomes with Imputed
Data
Sought medical care for acute effects
n = 103
Medical
care
βa
(95% CI)
p-value
Factor 1 (Model 19)
No
0.000
Reference
Yes
-0.796
(-1.286, -0.306) 0.0015

No
Yes

Factor 2 (Model 20)
0.000
Reference
-0.037
(-0.593, 0.519)

0.90

No
Yes

Cycle Score (Model 21)
0.000
Reference
-1.187
(-2.365, -0.010)

0.048

a

Adjusted for age, race, ethnicity, education, income, and trying to
conceive.
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Table 22: Multivariable Linear Models for Tear Gas Exposure Number and
Menstrual Cycle Outcomes
Number of exposures
n = 51
Exposures
1-2
>2

1-2
>2

1-2
>2
a

(95% CI)a

p-value

26 (51)
25 (49)

βa
Factor 1
0.000
0.938

Reference
(0.420, 1.457)

0.0010

26 (51)
25 (49)

Factor 2
0.000
0.361

Reference
(-0.234, 0.956)

0.24

n (%)

26 (51)
25 (49)

Cycle Score
0.000
Reference
2.182
(1.045, 3.320)

0.0005

Adjusted for age, race, ethnicity, education, income, and trying to conceive.
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A post hoc power investigation was conducted using G*Power Version 3.1.9.7
(64). F-tests with an alpha of 0.05 were performed for each main model [Table 23], as
well as the models with exposure number as the predictor [Table 24]. A calculated power
of 0.80 (80%) or above was considered to be sufficiently powered to detect an effect.
Three models were sufficiently powered: the Aim 1 models in which factor 1 and cycle
score were the outcomes, and the Aim 4 model in which factor 1 was the outcome. Post
hoc power calculations should be interpreted with caution as there are questions as to
how useful they are for indicating the true power of models (65, 66).
Table 23: Post Hoc Power Calculations for Main Models (α = 0.05)
Model

Main
Predictor

Main
Outcome

Sample
(n)

Partial R2

Power

0.4959
0.0504
0.2795

> 0.999
0.475
> 0.999

0.0002
0.0030
0.0015

0.052
0.074
0.062

0.0153
0.0019
0.0002

0.178
0.065
0.052

1
2
3

Protests

Factor 1
Factor 2
Cycle score

4
5
6

Acute score

Factor 1
Factor 2
Cycle score

7
8
9

Eye score

Factor 1
Factor 2
Cycle score

Aim 1
70
70
70
Aim 2
71
71
71
Aim 3
71
71
71

10
11
12

Lung score

Factor 1
Factor 2
Cycle score

71
71
71

0.0071
0.0004
0.0017

0.108
0.053
0.064

13
14
15

Skin score

Factor 1
Factor 2
Cycle score

71
71
71

0.0030
0.0005
0.0009

0.074
0.054
0.057

16

Heart score

Factor 1

71

0.0084

0.119

94

17
18
19
20
21

Factor 2
Cycle score
Medical care

Factor 1
Factor 2
Cycle score

71
71
Aim 4
62
62
62

0.0062
0.0010

0.100
0.058

0.1724
0.0055
0.0338

0.942
0.089
0.304

Table 24: Post Hoc Power Calculations for Tear Gas Exposure Models (α = 0.05)
Main
Outcome
Factor 1
Factor 2
Cycle score

Sample
(n)
51
51
51

95

Partial R2
0.2928
0.0329
0.3286

Power
0.994
0.251
0.998
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